secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001193125-26-214606
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics prices $760M public offering of 11.34M shares at $71/sh
--------------------------------------------------------------------

- Offering of 9,859,155 shares at $71.00 per share; underwriters' option for 1,478,873 shares exercised in full.
- Net proceeds of approximately $760.2 million after underwriting discounts and expenses.
- Underwriters include Morgan Stanley, Goldman Sachs, J.P. Morgan, and Jefferies.
- Offering made under automatic shelf registration statement filed February 27, 2025.
- Prospectus supplement dated May 6, 2026 filed with SEC on May 7, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000119312526214606/0001193125-26-214606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000119312526214606/d138544d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-214606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer